Recent Updates
Recently added Catalysts
MNDR Positive Sentiment Score: 75/100

Mobile-health Network Solutions Enters into Non-binding Strategic Memorandum to Facilitate Up to US$100 Million in Private Equity Funding for AI-Powered Healthcare Expansion Singapore

Key Takeaway: Mobile-health Network Solutions (MNDR) has signed a non-binding strategic memorandum with White Group Pte. Ltd. to facilitate up to $100 million in private equity funding aimed at expanding its AI-powered healthcare services. The funding will specifically support the development of advanced sports health and physiotherapy programs. White Group intends to identify a U.S.-based private equity fund for this collaboration, bringing MNDR closer to its goal of enhancing healthcare technology operations on a global scale. The roadmap ensures compliance with regulatory standards while aiming for a funding presentation within two months.

Market Sentiment Analysis

POSITIVE FACTORS

  • MNDR has entered a collaboration that may lead to up to $100 million in funding.
  • Funding aims to support the expansion of AI-powered healthcare technology initiatives.
  • New initiatives include advanced sports health physiotherapy programs.
  • The partnership emphasizes enhancing athlete care and global presence.

Full Press Release Details

Mobile-health Network Solutions Enters into Non-binding
Strategic Memorandum to Facilitate Up to US$100 Million in Private Equity Funding for AI-Powered Healthcare Expansion
Singapore, May 13, 2026 - Mobile-health
Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform,
today announced that it has entered into a Letter of Memorandum with White Group Pte. Ltd. (Singapore) ("White Group")
outlining a strategic collaboration to facilitate private equity funding of up to US$100 million to support MNDR's AI-powered
healthcare expansion and digital health infrastructure initiatives.
Under the memorandum, White Group has committed
to identifying and facilitating a U.S.-based private equity fund to partner with MNDR. The contemplated funding is intended to
support the initial launch and long-term scaling of MNDR's advanced healthcare technology operations. Any investment arising from
this process would be subject to customary reviews, approvals, and applicable regulatory requirements.
Focus on Advanced Sports Health and Digital Care
Proceeds from any funds raised through the private
equity facilitation are designated exclusively for MNDR's healthcare technology initiatives. These include the development and delivery
of sports health physiotherapy and treatment programs, as well as the support of male and female athletes competing at World
Championship-level sporting events.
Leadership Commentary
"MNDR, being the largest telehealth platform
in Singapore, is now bringing sports health into its ecosystem," said Peh Chin Hua, Chairman of White Group Pte. Ltd. "This
expansion will not only enhance athlete care but also increase its presence on the world stage."
Dr. Siaw Tung Yeng, Co-CEO of Mobile-health Network
Solutions, added that the partnership represents "a pivotal step in advancing AI-powered healthcare. By integrating sports health
and physiotherapy into our platform, we are creating a holistic digital health solution that empowers both everyday patients and elite
athletes worldwide."
Proposed Facilitation Structure
The memorandum outlines a proposed facilitation fee
structure whereby, upon each drawdown of funds (up to an aggregate of US$100 million), MNDR would issue a facilitation fee to the White
Group, payable either:
entirely in shares amounting to 5% of the drawn capital , or
a combination of 2.5% in shares and 2.5% in USD cash .
Any shares issued under the facilitation fee would
be based on the prevailing market price on each subsequent drawdown date.
As part of the execution roadmap, White Group plans
to present a suitable private equity fund candidate to the MNDR Board of Directors for review within approximately 60 days, with
an indicative target of July 2026. The parties have also acknowledged the importance of meeting applicable U.S. SEC disclosure
requirements in connection with any potential transaction.
Non-Binding Understanding
The Letter of Memorandum is non-binding and
reflects the parties' intent to explore a collaborative pathway to strengthen MNDR's capital base and accelerate its mission
in AI-driven global healthcare solutions.
About White Group Pte. Ltd.
White Group Pte. Ltd. is a privately owned boutique
investment and development firm based in Singapore, established in 2005. The group focuses on investing in and managing businesses that
create positive impact for people and society by addressing real-world challenges through innovative and practical solutions.
White Group partners with purpose-driven companies
and brands that seek to deliver tangible benefits to their communities. Its investment approach emphasizes long-term economic development
and sustainable growth across sectors such as technology, healthcare, and housing, leveraging innovation to drive meaningful outcomes.
With strategic interests primarily in China and
Southeast Asia, White Group acquires, invests in, and manages businesses operating in areas including real estate, technology, and
healthcare. The group's investments are guided by a commitment to building enduring value for partners while contributing to sustainable
and inclusive growth.
About Mobile-health Network Solutions
Mobile-health Network Solutions is a leading AI-powered
digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides
telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to
make healthcare accessible, intelligent, and human-through technology. For more information, please visit our website.
Forward-Looking Statements
Certain statements contained in this press release
about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute
"forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements
include, but are not limited to, statements relating to financial and business prospects, anticipated benefits of the Company's
advancement into sports health, the Company's goals and future activity, including continued development of proprietary and AI-driven
technologies, strategic partnerships, and its capital initiatives. The words "anticipate," "believe," "continue,"
"could," "estimate," "expect," "intend," "may," "plan," "potential,"
"predict," "project," "should," "target," "will," "would" and
similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying
words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual
results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject
to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage
growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations;
expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the
growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and
brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore
and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks
contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance
upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as
of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement,
whether because of new information, future events or otherwise, except as required by law.
For media inquiries, please contact:
Mobile-health Network Solutions Investor Relations Contact:
2 Venture Drive, #07-08 Vision Exchange
Investor Relations Inquiries:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835

Frequently Asked Questions

What is the purpose of the strategic memorandum?

The strategic memorandum aims to facilitate up to US$100 million in private equity funding for MNDR's AI-powered healthcare expansion.

Who is partnering with Mobile-health Network Solutions?

White Group Pte. Ltd. is partnering with MNDR to identify a U.S.-based private equity fund.

What focus areas will the funding support?

The funding will support healthcare technology initiatives, including sports health programs.

Is the Letter of Memorandum binding?

No, the Letter of Memorandum is non-binding and reflects an intent to collaborate.

What does MNDR aim to achieve with this funding?

MNDR aims to enhance digital health infrastructure and advance AI-powered healthcare technology.

Last updated: May 13, 2026